Company · CIK 0001637715 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
OnKure Therapeutics, Inc. · OKUR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 23, 4:54 pm EDT | Nicholas A SaccomanoPresident and CEO, Director | 87 | $2.97 | $259 | 11,160 | −0.77% | |
| Sep 21, 2026 SForm 4 → | Sep 23, 4:52 pm EDT | Jason A. LeveroneChief Financial Officer | 302 | $2.97 | $898 | 18,500 | −1.61% | |
| Jun 22, 2026 SForm 4 → | Jun 24, 7:29 pm EDT | Nicholas A SaccomanoPresident and CEO, Director | 86 | $4.40 | $378 | 11,247 | −0.76% | |
| Jun 22, 2026 SForm 4 → | Jun 24, 7:27 pm EDT | Jason A. LeveroneChief Financial Officer | 303 | $4.40 | $1,332 | 18,802 | −1.59% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 AForm 4 → | Aug 11, 4:43 pm EDT | Edward T MathersDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 AForm 4 → | Aug 11, 4:40 pm EDT | Liam RatcliffeDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 AForm 4 → | Aug 11, 4:39 pm EDT | Andrew John PhillipsDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 ADForm 4 → | Aug 11, 4:39 pm EDT | Isaac MankeDirector | 330,600 | — | — | 15,300 | — | amended |
| Aug 7, 2026 AForm 4 → | Aug 11, 4:37 pm EDT | Valerie Malyvanh JansenDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 AForm 4 → | Aug 11, 4:36 pm EDT | Michael G GreyDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 AForm 4 → | Aug 11, 4:31 pm EDT | R Michael CarruthersDirector | 22,350 | — | — | 22,350 | — | |
| Aug 7, 2026 ADForm 4 → | Aug 11, 4:27 pm EDT | Nicholas A SaccomanoPresident and CEO, Director | 1,292,846 | — | — | 542,232 | — | |
| Aug 7, 2026 ADForm 4 → | Aug 11, 4:26 pm EDT | Jason A. LeveroneChief Financial Officer | 333,428 | — | — | 130,611 | — | |
| Aug 7, 2026 ADForm 4 → | Aug 11, 4:25 pm EDT | Dylan HartleyChief Scientific Officer | 325,206 | — | — | 137,603 | — | |
| Aug 7, 2026 ADForm 4 → | Aug 11, 4:23 pm EDT | Samuel AgrestaChief Medical Officer | 349,968 | — | — | 131,396 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:32 pm EDT | Edward T MathersDirector | 7,650 | — | — | 7,650 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:27 pm EDT | Liam RatcliffeDirector | 1,275 | — | — | 1,275 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:26 pm EDT | Andrew John PhillipsDirector | 7,650 | — | — | 7,650 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:25 pm EDT | Valerie Malyvanh JansenDirector | 7,650 | — | — | 7,650 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:24 pm EDT | Michael G GreyDirector | 7,650 | — | — | 7,650 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:23 pm EDT | R Michael CarruthersDirector | 7,650 | — | — | 7,650 | — |